September 9th 2025
Ahead of the ESCRS congress and iNovation day, we go behind the scenes with Ciliatech founder Philippe Sourdille, MD, and president Olivier Benoit
August 6th 2025
Can AI compete with the well-oiled machine of the contemporary clinic?
July 23rd 2025
The nitric oxide-donating bimatoprost therapy is intended to lower intraocular pressure in patients with glaucoma or ocular hypertension
July 9th 2025
Phil Lai, MD, chief medical officer of Perfuse Therapeutics, said the company's goal is to pioneer disease-modifying treatment that targets an underlying pathology of ischemia
June 24th 2025
The framework covers ocular hypertension to severe progression
Rudin Glaucoma Prize winner announced
Dr Daniel Stamer has been awarded the prestigious Lewis Rudin Glaucoma Prize 2012.
Multiple micro-bypass stents lower IOP
Multiple micro-bypass stents with concurrent cataract surgery lowers IOP to less than 15 mmHg in patients with open-angle glaucoma (OAG) and cataract.
Ocular implant project receives €1.4 million
BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.
Macular scan OCT could be used for glaucoma
Macular scan OCT could be used for the diagnosis and management of glaucoma.
Anti-glaucoma eye drops linked to meibomian gland changes
The long-term use of anti-glaucoma eye drops is linked to changes in meibomian gland morphology and function.
Goniophotography and EyeCam imaging both highly sensitive
Goniophotography and EyeCam imaging are both highly sensitive for detecting gonioscopic angle closure.
Legal fitness to drive influenced by BEMD
Better eye mean deviation (BEMD) strongly affects a patient's legal fitness to drive (LFTD), according to recently published data.
ICS use maintains RNFL rate
Intranasal corticosteroids (ICS) maintain retinal nerve fibre layer (RNFL) thickness and optic nerve cup to disc ratio among patients with glaucoma or glaucoma suspect.
Contact lens sensor provides 24-hour IOP monitoring
A contact lens sensor is able to provide continuous 24-hour IOP monitoring for the management of glaucoma.
Statins reduce OAG risk in hyperlipidemia
The use of statins has been linked to a significant decrease in open-angle glaucoma (OAG) risk in patients with hyperlipidemia.
Caffeine increases IOP and OPP in POAG
Consuming one cup of caffeinated coffee statistically increases IOP and ocular perfusion pressure (OPP) in primary open-angle glaucoma (POAG) patients.
Glaucomatous damage detected with SD-OCT
SD-OCT imaging and retinal nerve fibre layer (RNFL) assessment successfully detects pre-perimetric glaucomatous damage.
Anterior chamber factors identified for OAG
Anterior chamber depth (ACD) and anterior chamber angle (ACA) were the factors identified relating to the progression of open-angle glaucoma (OAG).
IOP lowered with trab and combination trab
IOP is successfully reduced with both trabeculectomy and combined trabeculotomy-trabeculectomy with mitomycin C in children with glaucoma.
In the thick of it: parameters for glaucoma detection
Macular ganglion cell complex (mGCC) and peripapillary retinal nerve fiber layer (ppRNFL) thickness can be used as structural parameters for detecting preperimetric glaucoma.
UK charity donates generous funding for eye disease treatment
Fight for Sight has donated £1.6 million towards ten research grants focused on tackling sight loss and eye disease treatment.
VEGF levels in Tenon tissue linked to glaucoma surgery outcomes
Vascular endothelial growth factor (VEGF) levels in the Tenon tissue and final IOP is significantly correlated to 1-year surgical outcomes of glaucoma surgery in patients with primary open-angle glaucoma (POAG)
BRI incidence higher in MMC augmented trabeculectomy
Incidence of bleb-related infection (BRI) is higher in Mitomycin C (MMC) augmented trabeculectomy but is reduced to a lower level.
Modified DRPT better for detecting primary angle closure
Conducting a modified dark room provocative test (DRPT) is better for the diagnosis of primary angle closure, compared to gonioscopic angle assessment.
Safe and effective barrier against contamination during TSCPC
Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients.
Diverse factors affect management
Ever-widening knowledge base proves that there's more to it than controlling IOPs.
Trial compares glaucoma implants
Baerveldt device showed better outcomes but required more interventions then Ahmed valve.
Scleral spacing procedure and its indications in glaucoma treatment
Dr Soloway discusses a novel approach for treating glaucoma known as the scleral spacing procedure (SSP) using PresView Scleral Implants
Stability a strength of filtration device
Performance compares favourably with trabeculectomy, in physician's experience
Physician education boosts interaction
Strategy can improve patient compliance with glaucoma medication regimens.
Stem cell therapy closer to reality
Animals studies for neuroprotection in glaucoma have produced some promising results.
Canaloplasty heralds a new era in glaucoma surgery
Dr Matthias Grieshaber advises surgeons to implement this technique into their armamentarium.
Toxicity, therapeutics studied
Results of an in vitro study of the potentially adverse efefcts of five different topical glaucoma medications and preservatives are revealed
Ocular surface strategies are a must for treating patients with glaucoma
Alternatives for reducing preservative loads must be considered when assessing the ocular surface of patients being treated in the long-term with IOP-lowering medications
Laser affords multiple uses, benefits
A specific diode laser is the latest technology to perform several different laser procedures in the ophthalmic practice. Its multi-use capabilities for glaucoma and retinal disease make it a strong choice for the office setting.